Donald R. Howard, M.D., Ph.D.

Chairman of the Board and CEO

As Chairman and CEO, Dr. Howard leads CellNetix' best-in-class, highly sub-specialized pathology group and laboratories. He has authored numerous publications related to the imunobiology of malignant diseases, particularly breast cancer and lymphomas, and is a regular speaker at national pathology and laboratory conferences. Dr. Howard serves on the editorial advisory board of Washington G2 Reports.

Dr. Howard attended medical school at the Albany Medical College in New York and completed a Terry Fox Fellowship at the National Cancer Institute of Canada. He also completed residencies in Pathology at the University of Vermont College of Medicine in Burlington, in Pathology at the University of Southern California in Los Angeles, in Pathology at the University of California in San Francisco, and in Internal Medicine at the University of Southern California in Los Angeles.

Dr. Howard holds a Ph.D. in Experimental Pathology (Immunology) from the University of British Columbia in Vancouver. He has additional expertise in strategic and business management of pathology organizations, Immunopathology, and Transplant Pathology (Kidney).